Project Number 20131205-HYMAN-2013 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2013 View Full Project Details for APOE2-based gene therapy approaches to alleviate Alzheimer's disease neuropathological hallmarks Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) c. ApoE, Lipids and Lipoprotein Receptors Researcher and Organization Principal Investigator HYMAN, BRADLEY T Principal Investigator First Name BRADLEY Principal Investigator Last Name HYMAN Awardee Organization HARVARD UNIVERSITY Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement APOE RFP FY Overall Cost $250,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
